deltatrials
Completed NA INTERVENTIONAL 2-arm NCT06610188

The Effect of Inulin in Irritable Bowel Syndrome

The Effect of Inulin on Intestinal Symptoms, Depression and Quality of Life in Individuals With Constipation-Predominant Irritable Bowel Syndrome

Sponsor: Mardin Artuklu University

Conditions Bowel Symptoms Constipation Depression Disorders Inulin Irritable Bowel Syndrome (IBS) Quality of Life (QOL)
Interventions Maltodextrin (Placebo) Prebiotic group
Updated 2 times since 2024 Last updated: Sep 20, 2024 Started: Nov 3, 2021 Primary completion: Dec 3, 2021 Completion: Apr 1, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Bowel Symptoms and Constipation and is currently completed. Mardin Artuklu University leads this study, which shows 2 recorded versions since 2021 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Oct 2024 – ~Sep 2025 · 11 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Oct 2024 — Sep 2025 [monthly]

    Completed NA

    First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mardin Artuklu University
Data source: Mardin Artuklu University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations